Van Tuyl Christopher
- SEC CIK
- 0001779707
Latest role at each company
- IMVT Immunovant, Inc.Chief Legal Officeras of Sep 25, 2026
Trades
Every Form 4 that lists Van Tuyl Christopher as a reporting owner, including filings made jointly with others. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Company | Filed (ET) | Trade date | Insider | Transaction | Shares | Avg price | Value | Shares after | Holding change | Filing |
|---|---|---|---|---|---|---|---|---|---|---|
| IMVTImmunovant, Inc. | Sep 25, 20264:05 PM ET | Sep 23, 2026 | Van Tuyl ChristopherChief Legal Officer | SSaleCommon Stock | −2.85K | $36.36 | −$103.48K | 176.55K | −1.6% | SEC |
| IMVTImmunovant, Inc. | Jul 10, 20264:13 PM ET | Jul 8, 2026 | Van Tuyl ChristopherChief Legal Officer | SSaleCommon Stock | −1.21K | $39.554 | −$47.7K | 179.39K | −0.7% | SEC |
| IMVTImmunovant, Inc. | Jun 26, 2026 | Jun 26, 2026 | Van Tuyl ChristopherChief Legal Officer | SSaleCommon Stock | −17.82K | $38.3128 | −$682.89K | 180.6K | −9.0% | SEC |
| IMVTImmunovant, Inc. | Jun 22, 2026 | Jun 18, 2026 | Van Tuyl ChristopherChief Legal Officer | SSaleCommon Stock | −2.63K | $35.39 | −$93.22K | 180.6K | −1.4% | SEC |
| IMVTImmunovant, Inc. | Apr 10, 2026 | Apr 8, 2026 | Van Tuyl ChristopherChief Legal Officer | SSaleCommon Stock | −5.17K | $24.83 | −$128.25K | 183.23K | −2.7% | SEC |
| IMVTImmunovant, Inc. | Mar 20, 2026 | Mar 18, 2026 | Van Tuyl ChristopherChief Legal Officer | SSaleCommon Stock | −2.88K | $24.97 | −$71.84K | 147.05K | −1.9% | SEC |
| IMVTImmunovant, Inc. | Dec 19, 2025 | Dec 18, 2025 | Van Tuyl ChristopherChief Legal Officer | SSaleCommon Stock | −10.81K | $26.9067 | −$290.94K | 149.93K | −6.7% | SEC |